| abstract |
Disclosed herein are uses for a compound of Formula (I), below, or a pharmaceutically acceptable salt thereof: n n n n n n n n n n n n wherein n is an integer selected from the group of 0, 1, 2, 3, and 4, or a pharmaceutically acceptable salt thereof, for enhancing the effect of an anti-cancer agent, such as an inhibitor of CREB-mediated gene transcription. |